Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis
Abstract Background The impact of timing of genetic testing on surgical decision making in women with breast cancer and BRCA mutation is not well known. Methods Women who were found to carry a deleterious BRCA mutation and had been diagnosed with breast cancer were identified from a database at Beau...
Main Authors: | Siddhartha Yadav, Ashley Reeves, Sarah Campian, Amy Sufka, Dana Zakalik |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13053-017-0071-z |
Similar Items
-
Male BRCA mutation carriers: clinical characteristics and cancer spectrum
by: Mohammed Ibrahim, et al.
Published: (2018-02-01) -
Factors Considered by BRCA1/2 Carriers Regarding Timing of Risk-Reducing Mastectomy
by: Wilson, Katherine
Published: (2021) -
What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?
by: Elmira Ebrahimi, et al.
Published: (2018-11-01) -
Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
by: Athanasios Pouptsis, et al.
Published: (2020-10-01) -
Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis
by: Ziqi Jia, et al.
Published: (2021-09-01)